Joanne Cole

Oct 22, 2024 | nature.com | Silvia Bonas-Guarch |Fanny Mollandin |Joanne Cole |Josephine H. Li |Jose C. Florez |Anna L Gloyn | +4 more

Correction to: Nature Genetics https://doi.org/10.1038/s41588-024-01947-9, published online 8 October 2024. In the version of the article initially published, Alicia Huerta-Chagoya, Philip Schroeder, Ravi Mandla and Jiang Li were not listed as equal contributors and Uyenlinh L. Mirshahi, Alisa K. Manning, Aaron Leong, Miriam Udler and Josep M. Mercader were not listed as having jointly supervised the work. These corrections have been made to the HTML and PDF versions of the article.

Oct 8, 2024 | nature.com | Silvia Bonas-Guarch |Joanne Cole |Josephine H. Li |Jose C. Florez |Anna L Gloyn |Inês Cebola | +4 more

AbstractType 2 diabetes (T2D) genome-wide association studies (GWASs) often overlook rare variants as a result of previous imputation panels’ limitations and scarce whole-genome sequencing (WGS) data. We used TOPMed imputation and WGS to conduct the largest T2D GWAS meta-analysis involving 51,256 cases of T2D and 370,487 controls, targeting variants with a minor allele frequency as low as 5 × 10−5.